EMEA (Europe, Middle East and Africa) Parkinson's Disease Treatment Market Report 2018

January 2018 | 117 pages | ID: E24F6E9439AEN
QYResearch

Abstracts

In this report, the EMEA Parkinson's Disease Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Parkinson's Disease Treatment for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Parkinson's Disease Treatment market competition by top manufacturers/players, with Parkinson's Disease Treatment sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teva (Israel)
• Novartis AG (Switzerland)
• GSK (UK)
• AbbVie (US)
• Merck (US)
• Boehringer Ingelheim (Germany)
• Impax Laboratories (US)
• Lundbeck (Denmark)
• UCB (Belgium)
• Valeant Pharmaceuticals (Canada)
• Acadia (US)
• Sun Pharma (India)
• Wockhardt (India)
• Dr. Reddy's (India)
• Intas (India)
• US WorldMeds (US)
• Zydus Cadila (India)
• Cipla (India)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Levodopa/carbidopa
• Dopamine Receptor Agonists
• MAO-Inhibitors
• COMT-inhibitors
• Anticholinergics
• Other Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacies
• Retailer Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Parkinson's Disease Treatment Market Report 2017

1 PARKINSON'S DISEASE TREATMENT OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Treatment
1.2 Classification of Parkinson's Disease Treatment
  1.2.1 EMEA Parkinson's Disease Treatment Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Parkinson's Disease Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Levodopa/carbidopa
  1.2.4 Dopamine Receptor Agonists
  1.2.5 MAO-Inhibitors
  1.2.6 COMT-inhibitors
  1.2.7 Anticholinergics
  1.2.8 Other Drugs
1.3 EMEA Parkinson's Disease Treatment Market by Application/End Users
  1.3.1 EMEA Parkinson's Disease Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacies
  1.3.3 Retailer Pharmacies
  1.3.4 Online Pharmacies
1.4 EMEA Parkinson's Disease Treatment Market by Region
  1.4.1 EMEA Parkinson's Disease Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Parkinson's Disease Treatment (2012-2022)
  1.5.1 EMEA Parkinson's Disease Treatment Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Parkinson's Disease Treatment Revenue and Growth Rate (2012-2022)

2 EMEA PARKINSON'S DISEASE TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Parkinson's Disease Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Parkinson's Disease Treatment Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Parkinson's Disease Treatment Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Parkinson's Disease Treatment Sale Price by Players (2012-2017)
2.2 EMEA Parkinson's Disease Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Parkinson's Disease Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Parkinson's Disease Treatment Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Parkinson's Disease Treatment Sale Price by Type (2012-2017)
2.3 EMEA Parkinson's Disease Treatment (Volume) by Application
2.4 EMEA Parkinson's Disease Treatment (Volume and Value) by Region
  2.4.1 EMEA Parkinson's Disease Treatment Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Parkinson's Disease Treatment Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Parkinson's Disease Treatment Sales Price by Region (2012-2017)

3 EUROPE PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Parkinson's Disease Treatment Sales and Value (2012-2017)
  3.1.1 Europe Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
3.2 Europe Parkinson's Disease Treatment Sales and Market Share by Type
3.3 Europe Parkinson's Disease Treatment Sales and Market Share by Application
3.4 Europe Parkinson's Disease Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Parkinson's Disease Treatment Sales Volume by Countries (2012-2017)
  3.4.2 Europe Parkinson's Disease Treatment Revenue by Countries (2012-2017)
  3.4.3 Germany Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  3.4.4 France Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  3.4.5 UK Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  3.4.6 Russia Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  3.4.7 Italy Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Parkinson's Disease Treatment Sales and Value (2012-2017)
  4.1.1 Middle East Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
4.2 Middle East Parkinson's Disease Treatment Sales and Market Share by Type
4.3 Middle East Parkinson's Disease Treatment Sales and Market Share by Application
4.4 Middle East Parkinson's Disease Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Parkinson's Disease Treatment Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Parkinson's Disease Treatment Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  4.4.4 Israel Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  4.4.5 UAE Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  4.4.6 Iran Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)

5 AFRICA PARKINSON'S DISEASE TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Parkinson's Disease Treatment Sales and Value (2012-2017)
  5.1.1 Africa Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
5.2 Africa Parkinson's Disease Treatment Sales and Market Share by Type
5.3 Africa Parkinson's Disease Treatment Sales and Market Share by Application
5.4 Africa Parkinson's Disease Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Parkinson's Disease Treatment Sales Volume by Countries (2012-2017)
  5.4.2 Africa Parkinson's Disease Treatment Revenue by Countries (2012-2017)
  5.4.3 South Africa Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Parkinson's Disease Treatment Sales and Growth Rate (2012-2017)

6 EMEA PARKINSON'S DISEASE TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Teva (Israel)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teva (Israel) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis AG (Switzerland)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis AG (Switzerland) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK (UK)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK (UK) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 AbbVie (US)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AbbVie (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck (US)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim (Germany)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Impax Laboratories (US)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Impax Laboratories (US) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Lundbeck (Denmark)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Lundbeck (Denmark) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 UCB (Belgium)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 UCB (Belgium) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Valeant Pharmaceuticals (Canada)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Parkinson's Disease Treatment Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Acadia (US)
6.12 Sun Pharma (India)
6.13 Wockhardt (India)
6.14 Dr. Reddy's (India)
6.15 Intas (India)
6.16 US WorldMeds (US)
6.17 Zydus Cadila (India)
6.18 Cipla (India)

7 PARKINSON'S DISEASE TREATMENT MANUFACTURING COST ANALYSIS

7.1 Parkinson's Disease Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Parkinson's Disease Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Parkinson's Disease Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Parkinson's Disease Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PARKINSON'S DISEASE TREATMENT MARKET FORECAST (2017-2022)

11.1 EMEA Parkinson's Disease Treatment Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Parkinson's Disease Treatment Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Parkinson's Disease Treatment Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Parkinson's Disease Treatment Price and Trend Forecast (2017-2022)
11.2 EMEA Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Parkinson's Disease Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Parkinson's Disease Treatment Sales Forecast by Type (2017-2022)
11.7 EMEA Parkinson's Disease Treatment Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Parkinson's Disease Treatment
Figure EMEA Parkinson's Disease Treatment Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Parkinson's Disease Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Levodopa/carbidopa Product Picture
Figure Dopamine Receptor Agonists Product Picture
Figure MAO-Inhibitors Product Picture
Figure COMT-inhibitors Product Picture
Figure Anticholinergics Product Picture
Figure Other Drugs Product Picture
Figure EMEA Parkinson's Disease Treatment Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Parkinson's Disease Treatment by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retailer Pharmacies Examples
Table Key Downstream Customer in Retailer Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure EMEA Parkinson's Disease Treatment Market Size (Million USD) by Region (2012-2022)
Figure Europe Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Parkinson's Disease Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Parkinson's Disease Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Parkinson's Disease Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Parkinson's Disease Treatment Sales Volume and Growth Rate (2012-2022)
Figure EMEA Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Parkinson's Disease Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Parkinson's Disease Treatment Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Parkinson's Disease Treatment Sales Share by Players (2012-2017)
Figure 2016 Parkinson's Disease Treatment Sales Share by Players
Figure 2017 Parkinson's Disease Treatment Sales Share by Players
Figure EMEA Parkinson's Disease Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Parkinson's Disease Treatment Revenue (Million USD) by Players (2012-2017)
Table EMEA Parkinson's Disease Treatment Revenue Share by Players (2012-2017)
Table 2016 EMEA Parkinson's Disease Treatment Revenue Share by Players
Table 2017 EMEA Parkinson's Disease Treatment Revenue Share by Players
Table EMEA Parkinson's Disease Treatment Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Parkinson's Disease Treatment Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Parkinson's Disease Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Parkinson's Disease Treatment by Type (2012-2017)
Figure EMEA Parkinson's Disease Treatment Sales Market Share by Type (2012-2017)
Table EMEA Parkinson's Disease Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Parkinson's Disease Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Treatment by Type in 2016
Table EMEA Parkinson's Disease Treatment Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Parkinson's Disease Treatment Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Parkinson's Disease Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of Parkinson's Disease Treatment by Application (2012-2017)
Figure EMEA Parkinson's Disease Treatment Sales Market Share by Application in 2016
Table EMEA Parkinson's Disease Treatment Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Parkinson's Disease Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Parkinson's Disease Treatment by Region (2012-2017)
Figure EMEA Parkinson's Disease Treatment Sales Market Share in 2016
Table EMEA Parkinson's Disease Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Parkinson's Disease Treatment Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Treatment by Region (2012-2017)
Figure EMEA Parkinson's Disease Treatment Revenue Market Share Regions in 2016
Table EMEA Parkinson's Disease Treatment Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Parkinson's Disease Treatment Revenue and Growth Rate (2012-2017)
Table Europe Parkinson's Disease Treatment Sales (K Units) by Type (2012-2017)
Table Europe Parkinson's Disease Treatment Market Share by Type (2012-2017)
Figure Europe Parkinson's Disease Treatment Market Share by Type in 2016
Table Europe Parkinson's Disease Treatment Sales (K Units) by Application (2012-2017)
Table Europe Parkinson's Disease Treatment Market Share by Application (2012-2017)
Figure Europe Parkinson's Disease Treatment Market Share by Application in 2016
Table Europe Parkinson's Disease Treatment Sales (K Units) by Countries (2012-2017)
Table Europe Parkinson's Disease Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Parkinson's Disease Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Parkinson's Disease Treatment Sales Market Share by Countries in 2016
Table Europe Parkinson's Disease Treatment Revenue (Million USD) by Countries (2012-2017)
Table Europe Parkinson's Disease Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Parkinson's Disease Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Parkinson's Disease Treatment Revenue Market Share by Countries in 2016
Figure Germany Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure France Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure UK Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Parkinson's Disease Treatment Sales (K Units) by Type (2012-2017)
Table Middle East Parkinson's Disease Treatment Market Share by Type (2012-2017)
Figure Middle East Parkinson's Disease Treatment Market Share by Type (2012-2017)
Table Middle East Parkinson's Disease Treatment Sales (K Units) by Applications (2012-2017)
Table Middle East Parkinson's Disease Treatment Market Share by Applications (2012-2017)
Figure Middle East Parkinson's Disease Treatment Sales Market Share by Application in 2016
Table Middle East Parkinson's Disease Treatment Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Parkinson's Disease Treatment Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Parkinson's Disease Treatment Sales Volume Market Share by Countries in 2016
Table Middle East Parkinson's Disease Treatment Revenue (Million USD) by Countries (2012-2017)
Table Middle East Parkinson's Disease Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Parkinson's Disease Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Parkinson's Disease Treatment Revenue Market Share by Countries in 2016
Figure Saudi Arabia Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Parkinson's Disease Treatment Sales (K Units) by Type (2012-2017)
Table Africa Parkinson's Disease Treatment Sales Market Share by Type (2012-2017)
Figure Africa Parkinson's Disease Treatment Sales Market Share by Type (2012-2017)
Figure Africa Parkinson's Disease Treatment Sales Market Share by Type in 2016
Table Africa Parkinson's Disease Treatment Sales (K Units) by Application (2012-2017)
Table Africa Parkinson's Disease Treatment Sales Market Share by Application (2012-2017)
Figure Africa Parkinson's Disease Treatment Sales Market Share by Application (2012-2017)
Table Africa Parkinson's Disease Treatment Sales Volume (K Units) by Countries (2012-2017)
Table Africa Parkinson's Disease Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Parkinson's Disease Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Parkinson's Disease Treatment Sales Market Share by Countries in 2016
Table Africa Parkinson's Disease Treatment Revenue (Million USD) by Countries (2012-2017)
Table Africa Parkinson's Disease Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Parkinson's Disease Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Parkinson's Disease Treatment Revenue Market Share by Countries in 2016
Figure South Africa Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Table Teva (Israel) Parkinson's Disease Treatment Basic Information List
Table Teva (Israel) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure Teva (Israel) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table Novartis AG (Switzerland) Parkinson's Disease Treatment Basic Information List
Table Novartis AG (Switzerland) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure Novartis AG (Switzerland) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table GSK (UK) Parkinson's Disease Treatment Basic Information List
Table GSK (UK) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure GSK (UK) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table AbbVie (US) Parkinson's Disease Treatment Basic Information List
Table AbbVie (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure AbbVie (US) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table Merck (US) Parkinson's Disease Treatment Basic Information List
Table Merck (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure Merck (US) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Basic Information List
Table Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table Impax Laboratories (US) Parkinson's Disease Treatment Basic Information List
Table Impax Laboratories (US) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure Impax Laboratories (US) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table Lundbeck (Denmark) Parkinson's Disease Treatment Basic Information List
Table Lundbeck (Denmark) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure Lundbeck (Denmark) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table UCB (Belgium) Parkinson's Disease Treatment Basic Information List
Table UCB (Belgium) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure UCB (Belgium) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Basic Information List
Table Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales (K Units) and Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales Market Share in EMEA (2012-2017)
Figure Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Revenue Market Share in EMEA (2012-2017)
Table Acadia (US) Parkinson's Disease Treatment Basic Information List
Table Sun Pharma (India) Parkinson's Disease Treatment Basic Information List
Table Wockhardt (India) Parkinson's Disease Treatment Basic Information List
Table Dr. Reddy's (India) Parkinson's Disease Treatment Basic Information List
Table Intas (India) Parkinson's Disease Treatment Basic Information List
Table US WorldMeds (US) Parkinson's Disease Treatment Basic Information List
Table Zydus Cadila (India) Parkinson's Disease Treatment Basic Information List
Table Cipla (India) Parkinson's Disease Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Treatment
Figure Manufacturing Process Analysis of Parkinson's Disease Treatment
Figure Parkinson's Disease Treatment Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Treatment Major Manufacturers in 2016
Table Major Buyers of Parkinson's Disease Treatment
Table Distributors/Traders List
Figure EMEA Parkinson's Disease Treatment Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Parkinson's Disease Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Parkinson's Disease Treatment Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Parkinson's Disease Treatment Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Parkinson's Disease Treatment Sales Market Share Forecast by Region (2017-2022)
Table EMEA Parkinson's Disease Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Parkinson's Disease Treatment Revenue Market Share Forecast by Region (2017-2022)
Table Europe Parkinson's Disease Treatment Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Parkinson's Disease Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Europe Parkinson's Disease Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Parkinson's Disease Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Parkinson's Disease Treatment Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Parkinson's Disease Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Parkinson's Disease Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Parkinson's Disease Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Parkinson's Disease Treatment Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Parkinson's Disease Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Africa Parkinson's Disease Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Parkinson's Disease Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Parkinson's Disease Treatment Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Parkinson's Disease Treatment Sales Market Share Forecast by Type (2017-2022)
Table EMEA Parkinson's Disease Treatment Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Parkinson's Disease Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources